Academy of Oncologic Physical Therapy EDGE Task Force: A Systematic Review of Measures of Balance in Adult Cancer Survivors

Huang, Min; Croarkin, Earllaine; Wampler-Kuhn, Meredith; Blackwood, Jennifer; Colon, Genevieve; Pfalzer, Lucinda

doi:10.1097/01.reo.0000000000000177

Cited by 19 publications

(17 citation statements)

References 69 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The tester began timing when they said “go” and counted how many full sit-to-stand repetitions the participant completed in 30 seconds. This test has reported test-retest reliability and criterion validity in community-dwelling older adults[ 23 ] and excellent test-retest reliability but poor concurrent validity in head and neck cancer survivors[ 30 ].…”

Section: Methodsmentioning

confidence: 99%

“…An even more comprehensive measure, the Physical Performance Test-7 (PPT-7), has additional items assessing independence in ADL performance[ 28 ]. Two systematic reviews were published, one in 2016 and later 2019, describing the clinical utility of measures of function in cancer survivors[ 29 , 30 ]. From those reviews, the authors designated the 5xSTS and SPPB as ‘highly recommended or recommended for clinical use’ in prostate or breast cancer survivors.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Physical function measurement in older long-term cancer survivors

Blackwood

Rybicki

2021

JFSF

Self Cite

View full text Add to dashboard Cite

Objective: To establish reliability, validity, and minimal detectable change in measures of function in older long-term cancer survivors. Methods: Older cancer survivors were recruited to perform functional measures; 5 Times Sit-to-Stand (5xSTS), 30-second Timed Chair Rise (30sTCR), Short Physical Performance Battery (SPPB), Physical Performance Test-7 (PPT-7). Two testing sessions were completed two weeks apart. Test-retest reliability was examined using the intraclass correlation coefficient (ICC 2,1 ), convergent and discriminant validity using Spearman’s rho and Minimal Detectable Change (MDC 95 ) was calculated. Results: Forty-seven older long-term cancer survivors participated. Test-retest reliability was good for 5xSTS (ICC 2,1 =0.86), 30sTCR (ICC 2,1 =0.89), and SPPB (ICC 2,1 =0.85) and poor for PPT-7 (ICC 2,1 =0.48). Both convergent and discriminant validity was established. Conclusions: SPPB, 5xSTS, and 30sTCR are reliable and valid tools to measure function in older long-term cancer survivors. MDC 95 values were larger than those reported in geriatrics and should be interpreted with caution. Residual effects of cancer treatment, comorbidity, and physical inactivity may contribute to decreased physical function in older long-term cancer survivors, therefore valid and reliable measures like SPPB and the timed chair rise tests should be used objectively measure function throughout the survivorship spectrum.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Physical function measurement in older long-term cancer survivors

Blackwood

Rybicki

2021

JFSF

Self Cite

View full text Add to dashboard Cite

show abstract

“…A 2019 systematic review conducted by members of the Academy of Oncologic Physical Therapy EDGE Task Force used the Cancer EDGE Rating Scale to assess and make recommendations on measures used to assess balance in cancer survivors. 11 In this review, GS was "highly recommended," with a score of "4" indicating that the outcome measure has excellent psychometric properties in the condition of interest (eg, cancer population) and excellent clinical utility and that the tool is free or reasonably accessible to a broad range of providers. 11 TUG was given a score of "3" or "recommended" for use.…”

mentioning

confidence: 99%

“…11 In this review, GS was "highly recommended," with a score of "4" indicating that the outcome measure has excellent psychometric properties in the condition of interest (eg, cancer population) and excellent clinical utility and that the tool is free or reasonably accessible to a broad range of providers. 11 TUG was given a score of "3" or "recommended" for use. 11 A rating of "3" means that the tool has good psychometric properties but lacks some information about reliability, validity, or responsiveness in the condition of interest or may require access to specialized testing equipment.…”

mentioning

confidence: 99%

“…11 TUG was given a score of "3" or "recommended" for use. 11 A rating of "3" means that the tool has good psychometric properties but lacks some information about reliability, validity, or responsiveness in the condition of interest or may require access to specialized testing equipment. 11 Despite the EDGE ratings, the psychometric data for use in GS and TUG measures are limited in older cancer survivors.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Mobility Measures in Older Cancer Survivors: An Examination of Reliability, Validity, and Minimal Detectable Change

Blackwood¹,

Rybicki²,

Huang³

2020

Rehabilitation Oncology

Self Cite

View full text Add to dashboard Cite

Background: Cancer and its treatment contribute to multiple sequelae affecting physical function, including difficulty in balance and walking. Although clinical tests should be used to assess fall risks in older cancer survivors, the literature describing the validity, reliability, measurement error, and minimal detectable change (MDC) of mobility measures is lacking. Objective: The purpose of this study was to describe the reliability, validity, standard error of the measurement (SEM), and minimal detectable change at 95% confidence (MDC 95 ) of mobility measures in older cancer survivors. Methods: Fifty cancer survivors (breast, prostate, lung, or colorectal) aged 65+ years participated. Measures of gait speed (GS) (usual, fast, and dual-task) and mobility (Timed Up and Go [TUG], TUG-cognitive, and TUG-manual) were performed once and then repeated 2 weeks later. Test-retest reliability was assessed using intraclass correlation coefficient (ICC 2,1 ). MDC 95 and SEM were calculated. Construct validity was examined using Pearson's correlation coefficient with 6-item Activitiesspecific Balance Confidence scale and Short Physical Performance Battery performance. Results: Test-retest reliability was excellent for all mobility measures, with ICC values ranging from 0.89 to 0.94 for GS and 0.95 to 0.98 for TUG measures. Construct validity was present for TUG (r = −0.53 to −0.73) and GS (r = 0.29 to 0.5) measures. Low SEM values demonstrated excellent reproducibility. To be considered real change, usual GS should be 0.14 m/s or more and TUG 2.49 seconds or more. Conclusions: Measures of GS and TUG have excellent reliability and construct validity and should be considered for use in older cancer survivors. Further study is indicated to establish the psychometric values of mobility measures by cancer type.

show abstract

Development of a core set of outcome measures to be applied toward breast cancer-related lymphedema core outcome domains

Doubblestein,

Koehler,

Anderson

et al. 2024

Breast Cancer Res Treat

View full text Add to dashboard Cite

Purpose For breast cancer survivors (BCS) living with breast cancer-related lymphedema (BCRL), what outcome measures (OMs) are recommended to be used to measure standardized outcome domains to fully assess the burden of the disease and efficacy of interventions? An integral component of a standardized core outcome set (COS) are the OMs used to measure the COS. Methods A supplemental online survey was linked to a Delphi study investigating a COS for BCRL. OMs were limited to a maximum of 10 options for each outcome domain (OD). There were 14 ODs corresponding to the International Classification of Functioning, Disability, and Health (ICF) framework and respondents rated the OMs with a Likert level of recommendation. The feasibility of the listed OMs was also investigated for most outpatient, inpatient, and research settings. Results This study identified 27 standardized OMs with a few ODs having 2–3 highly recommended OMs for proper measurement. A few of the recommended OMs have limitations with reliability due to being semi-quantitative measures requiring the interpretation of the rater. Conclusion Narrowing the choices of OMs to 27 highly recommended by BCRL experts may reduce selective reporting, inconsistency in clinical use, and variability of reporting across interdisciplinary healthcare fields which manage or research BCRL. There is a need for valid, reliable, and feasible OMs that measure tissue consistency. Measures of upper extremity activity and motor control need further research in the BCS with BCRL population.

show abstract

Academy of Oncologic Physical Therapy EDGE Task Force: A Systematic Review of Measures of Balance in Adult Cancer Survivors

Cited by 19 publications

References 69 publications

Physical function measurement in older long-term cancer survivors

Physical function measurement in older long-term cancer survivors

Mobility Measures in Older Cancer Survivors: An Examination of Reliability, Validity, and Minimal Detectable Change

Development of a core set of outcome measures to be applied toward breast cancer-related lymphedema core outcome domains

Contact Info

Product

Resources

About